AK Medical Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,384	1,346	1,094	1,052	761.44	1,035
Revenue Growth (YoY)	25.51%	23.09%	3.98%	38.16%	-26.46%	11.73%
Cost of Revenue	563.45	538.18	419.38	415.61	262.25	320.85
Gross Profit	820.05	808.19	674.49	636.44	499.19	714.53
Selling, General & Admin	394.23	384.86	352.25	298.42	292.66	237.12
Research & Development	142.33	139.21	137.13	110.87	113.07	104.97
Other Operating Expenses	-32.01	-16.65	-26.37	-11.19	-5.98	-5.33
Operating Expenses	504.55	507.41	463	398.09	399.75	336.76
Operating Income	315.5	300.78	211.48	238.34	99.44	377.77
Interest Expense	-1.22	-0.92	-1.29	-2.17	-1.61	-1.28
Interest & Investment Income	26.86	23.37	22.77	17.75	8.99	12.96
Currency Exchange Gain (Loss)	2.83	-3.41	-1.85	4.73	1.74	-4
EBT Excluding Unusual Items	343.97	319.82	231.12	258.65	108.56	385.46
Impairment of Goodwill	-	-	-	-18.36	-	-8.85
Pretax Income	343.97	319.82	231.12	240.29	108.56	376.61
Income Tax Expense	48.69	45.9	49.01	35.52	15.94	62.6
Net Income	295.28	273.93	182.1	204.77	92.62	314.01
Net Income to Common	295.28	273.93	182.1	204.77	92.62	314.01
Net Income Growth	56.42%	50.42%	-11.07%	121.09%	-70.50%	17.61%
Shares Outstanding (Basic)	1,116	1,116	1,113	1,109	1,113	1,102
Shares Outstanding (Diluted)	1,119	1,119	1,119	1,117	1,121	1,107
Shares Change (YoY)	0.11%	-0.05%	0.15%	-0.28%	1.21%	4.61%
EPS (Basic)	0.26	0.25	0.16	0.18	0.08	0.28
EPS (Diluted)	0.26	0.24	0.16	0.18	0.08	0.28
EPS Growth	62.57%	50.00%	-11.11%	125.00%	-71.43%	12.00%
Free Cash Flow	408.5	298.25	-149.86	127.72	117.86	120.01
Free Cash Flow Per Share	0.36	0.27	-0.13	0.11	0.10	0.11
Dividend Per Share	0.068	0.068	0.041	0.053	0.020	0.034
Dividend Growth	65.64%	65.64%	-23.04%	160.59%	-39.53%	-49.76%
Gross Margin	59.27%	60.03%	61.66%	60.49%	65.56%	69.01%
Operating Margin	22.80%	22.34%	19.33%	22.66%	13.06%	36.49%
Profit Margin	21.34%	20.34%	16.65%	19.46%	12.16%	30.33%
Free Cash Flow Margin	29.53%	22.15%	-13.70%	12.14%	15.48%	11.59%
EBITDA	404.2	377.69	282.36	300.3	156.85	421.38
EBITDA Margin	29.22%	28.05%	25.81%	28.54%	20.60%	40.70%
D&A For EBITDA	88.7	76.91	70.88	61.95	57.42	43.6
EBIT	315.5	300.78	211.48	238.34	99.44	377.77
EBIT Margin	22.80%	22.34%	19.33%	22.66%	13.06%	36.49%
Effective Tax Rate	14.15%	14.35%	21.21%	14.78%	14.68%	16.62%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.